A new system decodes brain signals from the motor cortex of monkeys and translates them into basic arm movements, despite temporary paralysis.
A new system decodes brain signals from the motor cortex of monkeys and translates them into basic arm movements, despite temporary paralysis.
Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.
Snails with implanted electrodes generate electricity via metabolism.
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
The federal agency finally breaks out some information on what it might take to get generic biological drugs approved.
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
Critics are shaming the European Commission for directing research funds to a laboratory operating in the occupied West Bank.
A prominent researcher is being sued for $1 billion by a University of Pennsylvania Cancer Institute for discoveries he may have made while a researcher and administrator there.
Our list of the best and brightest products that 2011 had to offer the life scientist